Abbott Molecular is a leader in molecular diagnostics and an experienced global healthcare partner in companion diagnostic development. Our tests can detect subtle but key changes in patients’ genes and chromosome, have the potential to aid with early detection or diagnosis, can influence the selection of appropriate therapies, and may assist with monitoring of disease progression.
ANGLE’s Parsortix technology enables the capture and harvest of circulating tumor cells from patient blood. The resulting liquid biopsy (simple blood test) provides a powerful tool to deliver personalized cancer care. ANGLE is currently developing its first diagnostic product in the area of ovarian cancer. The Parsortix system has CE Mark regulatory approval in Europe and an FDA approval process is underway in the US.
Our unique perspectives, built from decades of scientific expertise and precision delivery of the largest volume of drug development data in the world, helps our clients identify new approaches and anticipate tomorrow’s challenges as they evolve. Driven by a passion for excellence and a relentless commitment to quality, we unlock opportunities that advance innovation and deliver on the promise of a healthier world.
NanoString Technologies is a provider of life science tools for translational research and developer of molecular diagnostic products. The company’s nCounter® Analysis System delivers highly-multiplexed, direct profiling of individual molecules in a single reaction without amplification. Applications include Gene Expression, Single-Cell, miRNA and CNV.”
Thermo Fisher Scientific Inc. is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. Through our four premier brands – Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support.
Almac partners with the biopharmaceutical industry to provide biomarker discovery and development solutions ranging from pre-clinical biomarker discovery, through to full companion diagnostic development, biomarker clinical trial management and clinical test delivery from our CLIA lab.
Biocartis aims to provide direct access to personalized medicine for patients worldwide by developing fully integrated and broadly applicable molecular diagnostics. Our platforms can be used in a wide variety of healthcare settings to enable rapid and high-quality care close to patients.
Celsee Diagnostics provides automated label-free platforms for circulating tumor cell (CTC) enrichment and analysis. The simple-to-use PREP platform uses whole blood and performs all the processing steps to detect, enrich and execute downstream single-cell analysis, including immunochemistry, DNA FISH and mRNA FISH. CTCs can be isolated for PCR and NGS applications. The add-on ANALYZER imaging station scans and analyzes the prepared slides.